← Back to headlines
Merck's Welireg Receives FDA Label Expansion for Kidney Cancer
Merck announced that its drug Welireg has received an FDA label expansion, allowing its use in treating kidney cancer.
12 Jun, 17:11 — 12 Jun, 17:11
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
2h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
9h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
12h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
20h ago